These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 25647750)

  • 1. Association of depressive and anxiety symptoms with 24-hour urinary catecholamines in individuals with untreated high blood pressure.
    Paine NJ; Watkins LL; Blumenthal JA; Kuhn CM; Sherwood A
    Psychosom Med; 2015; 77(2):136-44. PubMed ID: 25647750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression and anxiety symptoms are related to increased 24-hour urinary norepinephrine excretion among healthy middle-aged women.
    Hughes JW; Watkins L; Blumenthal JA; Kuhn C; Sherwood A
    J Psychosom Res; 2004 Oct; 57(4):353-8. PubMed ID: 15518669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese.
    Lee ZS; Critchley JA; Tomlinson B; Young RP; Thomas GN; Cockram CS; Chan TY; Chan JC
    Metabolism; 2001 Feb; 50(2):135-43. PubMed ID: 11229419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour autonomic nervous function in sustained and "white coat" hypertension.
    Pierdomenico SD; Bucci A; Costantini F; Lapenna D; Cuccurullo F; Mezzetti A
    Am Heart J; 2000 Oct; 140(4):672-7. PubMed ID: 11011344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [24-hour ambulatory monitoring of arterial blood pressure and the sympathetic nervous system in hypertensive smokers].
    Gambini G; Di Cato L; Pinchi G; Valori C
    G Ital Cardiol; 1997 Nov; 27(11):1153-7. PubMed ID: 9463059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary catecholamines in essential hypertension: results of 24-hour urine catecholamine analyses from patients in the Medical Research Council trial for mild hypertension and from matched controls.
    Brown MJ; Causon RC; Barnes VF; Brennan P; Barnes G; Greenberg G
    Q J Med; 1985 Oct; 57(222):637-51. PubMed ID: 4080953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mania: sympathoadrenal function and clinical state.
    Swann AC; Secunda SK; Koslow SH; Katz MM; Bowden CL; Maas JW; Davis JM; Robins E
    Psychiatry Res; 1991 May; 37(2):195-205. PubMed ID: 1876629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overnight excretion of urinary catecholamines and metabolites in the detection of pheochromocytoma.
    Peaston RT; Lennard TW; Lai LC
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1378-84. PubMed ID: 8636337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms are related to higher ambulatory blood pressure in people with a family history of hypertension.
    Grewen KM; Girdler SS; Hinderliter A; Light KC
    Psychosom Med; 2004; 66(1):9-16. PubMed ID: 14747632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary Norepinephrine Is a Metabolic Determinant of 24-Hour Energy Expenditure and Sleeping Metabolic Rate in Adult Humans.
    Hollstein T; Basolo A; Ando T; Votruba SB; Krakoff J; Piaggi P
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1145-56. PubMed ID: 32002540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of plasma and urinary catecholamine levels in normotensive and hypertensive men and women.
    Saxena AR; Chamarthi B; Williams GH; Hopkins PN; Seely EW
    J Hum Hypertens; 2014 May; 28(5):292-7. PubMed ID: 24226101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depressive symptoms and 24-hour urinary norepinephrine excretion levels in patients with coronary disease: findings from the Heart and Soul Study.
    Otte C; Neylan TC; Pipkin SS; Browner WS; Whooley MA
    Am J Psychiatry; 2005 Nov; 162(11):2139-45. PubMed ID: 16263855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of sympathetic activity on blood pressure and vascular damage evaluated by means of urinary albumin excretion.
    Mena-Martín FJ; Martín-Escudero JC; Simal-Blanco F; Carretero-Ares JL; Arzúa-Mouronte D; Castrodeza Sanz JJ;
    J Clin Hypertens (Greenwich); 2006 Sep; 8(9):619-24. PubMed ID: 16957423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between cognitive function, depressive behaviour and sleep quality with 24-h urinary sodium excretion in patients with essential hypertension.
    Afsar B
    High Blood Press Cardiovasc Prev; 2013 Mar; 20(1):19-24. PubMed ID: 23529378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bereavement and catecholamines.
    Jacobs SC; Mason JW; Kosten TR; Wahby V; Kasl SV; Ostfeld AM
    J Psychosom Res; 1986; 30(4):489-96. PubMed ID: 3761233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety, depressive symptoms, and cardiac autonomic function in perimenopausal and postmenopausal women with hot flashes: a brief report.
    Fu P; Gibson CJ; Mendes WB; Schembri M; Huang AJ
    Menopause; 2018 Dec; 25(12):1470-1475. PubMed ID: 29916944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the arterial blood pressure and nonhemodynamic factors on left ventricular hypertrophy in moderate essential hypertension.
    Bauwens FR; Duprez DA; De Buyzere ML; De Backer TL; Kaufman JM; Van Hoecke J; Vermeulen A; Clement DL
    Am J Cardiol; 1991 Oct; 68(9):925-9. PubMed ID: 1833970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obstructive sleep apnea syndrome and essential hypertension: diurnal variation of urinary catecholamines].
    Guo XH
    Zhonghua Nei Ke Za Zhi; 1992 Oct; 31(10):619-22, 658. PubMed ID: 1306454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the sympathetic firing pattern and anxiety level in patients with the metabolic syndrome and elevated blood pressure.
    Lambert E; Dawood T; Straznicky N; Sari C; Schlaich M; Esler M; Lambert G
    J Hypertens; 2010 Mar; 28(3):543-50. PubMed ID: 20139772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating catecholamines are associated with biobehavioral factors and anxiety symptoms in head and neck cancer patients.
    Bastos DB; Sarafim-Silva BAM; Sundefeld MLMM; Ribeiro AA; Brandão JDP; Biasoli ÉR; Miyahara GI; Casarini DE; Bernabé DG
    PLoS One; 2018; 13(8):e0202515. PubMed ID: 30125310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.